NAT2, XRCC1 and hOGG1 polymorphisms, cigarette smoking, alcohol consumption and risk of upper aerodigestive tract cancer.
暂无分享,去创建一个
Aguinaldo Luiz Simões | Cintia Rodrigues Marques | Thiago Magalhães Da Silva | Dulcineia Martins De Albuquerque | Meiryane Santos Chaves | Marcilio Ferreira Marques Filho | Jamille Silva Oliveira | Giuliano Di Pietro | Sandra Mara Bispo Sousa | Fabrício Rios-Santos | A. L. Simões | F. Rios-Santos | S. Sousa | C. Marques | G. Di Pietro | T. M. da Silva | M. F. Marques Filho | D. M. de Albuquerque | J. S. Oliveira
[1] J. Little,et al. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. , 2000, American journal of epidemiology.
[2] Jun Liu,et al. HOGG 1 Ser 326 Cys Polymorphism and Susceptibility to Head and Neck Cancer : a Meta-analysis , 2012 .
[3] J. Yokota,et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA , 1998, Oncogene.
[4] L. Magno,et al. Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations , 2010, BMC Genetics.
[5] I. Kato,et al. Alcohol in the aetiology of upper aerodigestive tract cancer. , 1994, European journal of cancer. Part B, Oral oncology.
[6] P. Brennan,et al. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. , 2006, Oral oncology.
[7] P. Porter,et al. N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. , 2001, Carcinogenesis.
[8] D. Bell,et al. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. , 1995, Cancer research.
[9] M. Romkes,et al. Case–control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes , 2008, Head & neck.
[10] E. Vokes,et al. Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer , 2008, CA: a cancer journal for clinicians.
[11] D. Hein. Acetylator genotype and arylamine-induced carcinogenesis. , 1988, Biochimica et biophysica acta.
[12] Y. Kuroda,et al. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. , 2008, Japanese journal of clinical oncology.
[13] Peter Dalgaard,et al. R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .
[14] J. Brockmöller,et al. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. , 1996, Cancer research.
[15] M. Karagas,et al. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. , 2002, Cancer research.
[16] P. Chyou,et al. Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites , 1992, Cancer Causes & Control.
[17] P. Vineis,et al. The Role of Genetically-based Metabolic Polymorphisms in Human Cancer : An Ecological Study of Bladded Cancer and N-Acetyltransferase in 23 Populations , 1998, Biotherapy.
[18] A. Mitra,et al. Protective association exhibited by the single nucleotide polymorphism (SNP) rs1052133 in the gene human 8-oxoguanine DNA glycosylase (hOGG1) with the risk of squamous cell carcinomas of the head & neck (SCCHN) among north Indians , 2011, The Indian journal of medical research.
[19] Laurent Excoffier,et al. Arlequin (version 3.0): An integrated software package for population genetics data analysis , 2005, Evolutionary bioinformatics online.
[20] D. Pang,et al. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis , 2010, Breast Cancer Research and Treatment.
[21] D. Hein. N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. , 2009, Expert opinion on drug metabolism & toxicology.
[22] J. Radicella,et al. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. , 2000, Archives of biochemistry and biophysics.
[23] Qi Song-tao,et al. Association between the XRCC1 Arg399Gln Polymorphism and Risk of Cancer: Evidence from 297 Case–Control Studies , 2013, PloS one.
[24] D. Grant,et al. Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[25] P. Brennan,et al. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. , 2005, American journal of epidemiology.
[26] M. Shriver,et al. Ancestral proportions and their association with skin pigmentation and bone mineral density in Puerto Rican women from New York city , 2004, Human Genetics.
[27] Shizhi Wang,et al. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies. , 2012, Mutagenesis.
[28] M. Rydzanicz,et al. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. , 2005, Mutation research.
[29] G. Williamson,et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL Radiology , 2014 .
[30] F. Salzano,et al. Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity , 2007, The Pharmacogenomics Journal.